화요일, 7월 23, 2024
HomeMen's HealthNovel molecule might inform new therapies for stroke-related mind harm

Novel molecule might inform new therapies for stroke-related mind harm



A newly developed molecule, LK-2, might inform new therapies for stroke-related mind harm, finds scientists at The Hospital for Sick Youngsters (SickKids). 

An ischemic stroke happens when blood circulation to part of the mind is interrupted, depriving the mind cells of oxygen and vitamins. With out well timed remedy, mind cells can die, leading to everlasting injury to the mind and its features. Stroke is among the main causes of demise and incapacity worldwide, affecting thousands and thousands yearly. 

A world examine printed in Nature co-led by Dr. Lu-Yang Wang, a Senior Scientist within the Neurosciences & Psychological Well being program at SickKids, and clinician scientists on the Shanghai Jiao Tong College Faculty of Medication, has uncovered a molecule that holds the potential to guard neurons throughout stroke and stop stroke-related mind injury.

“Our findings present a wholly new approach to consider saving cells whereas minimizing the opposed neural unwanted side effects of standard stroke remedy,” says Wang, who holds a Tier 1 Canada Analysis Chair in Mind Improvement and Problems. “The LK-2 molecule may very well be the important thing to unlocking profitable therapeutics for stroke sufferers.” 

How one neurotransmitter is contributing to stroke-related mind injury 

One of many most important culprits behind stroke-induced mind injury is a neurotransmitter referred to as glutamate. When the mind is starved of oxygen and sugar, glutamate ranges rise dramatically, overstimulating N-methyl-Daspartate receptors (NMDARs) on the membrane of mind cells. This causes a surge of calcium to enter cells, triggering a cascade of occasions that finally results in cell demise. 

For many years, researchers have tried to develop medication that may block NMDARs and stop the neurotoxicity that comes with elevated ranges of glutamate. Nonetheless, earlier medication focusing on NMDARs have been ineffective and failed to maneuver past medical trials as a result of NMDARs play necessary roles in common mind features, equivalent to studying and reminiscence. As well as, blocking NMDARs fully could cause severe unwanted side effects, equivalent to psychosis and cognitive impairment. 

The workforce discovered that glutamate can even bind to and activate a sort of acidosis sensor referred to as acid-sensing ion channels (ASICs), that are usually activated by acids. ASICs are current within the membrane of mind cells – like NMDARs – and may enable calcium ions to enter the cells when stimulated. 

We’ve proven that glutamate can supercharge the exercise of ASICs, particularly beneath the acidic situations that happen throughout stroke. Which means glutamate is attacking mind cells via each NMDARs and ASICs – one thing we didn’t know prior to now.” 


Dr. Lu-Yang Wang, Senior Scientist within the Neurosciences & Psychological Well being program at SickKids

A brand new option to block extra glutamate 

By figuring out the particular web site in ASICs the place glutamate binds, the workforce was capable of develop a brand new molecule, referred to as LK-2, that may selectively block the glutamate binding web site in ASICs, however depart NMDARs intact. 

In preclinical fashions, the workforce discovered that LK-2 successfully prevented glutamate from overstimulating ASICs to scale back the circulation calcium and cell demise. Moreover, LK-2 didn’t have an effect on NMDARs or different common neural transmissions, which suggests its potential as the following technology of stroke therapeutics. 

“Our analysis has revealed a brand new option to defend the mind from glutamate toxicity with out interfering with NMDARs,” Wang says.

Wang’s analysis will proceed to discover the operate and mechanisms of LK-2, within the hopes of growing future medical trials. 

The analysis workforce needs to thank Dr. Julie Forman-Kay, a Senior Scientist and Program Head of the Molecular Medication program, and Dr. Iva Pritišanac, a postdoctoral fellow in Forman-Kay’s lab, who assisted Wang in finding the binding websites for glutamate on ASICs. 

This analysis is funded at SickKids by the Canadian Institutes of Well being Analysis (CIHR), the Pure Sciences and Engineering Analysis Council of Canada (NSERC) and Canada Analysis Chair Program.

Supply:

Journal reference:

Lai, Okay., et al. (2024). Glutamate acts on acid-sensing ion channels to worsen ischaemic mind harm. Nature. doi.org/10.1038/s41586-024-07684-7.

RELATED ARTICLES
RELATED ARTICLES

Most Popular